OPTOLANE uses Trustonic protection in new diagnostic devices

OPTOLANE uses Trustonic protection in new diagnostic devices

By eeNews Europe

OPTOLANE’s new device has been developed to be used at the point-of-care for early diagnosis and preventative healthcare, particularly for diagnosing cancer, infectious diseases and congenital abnormalities. It is based on Nexell’s SoC platform, which integrates Trustonic’s Trusted Execution Environment (TEE). The in vitro diagnostic (IVD) platform is called LOAA (Lab on an Array) Analyzer. It is designed to examine blood and tissue samples for multiple targets, including DNA, RNA, proteins and metabolites, in real-time. It was developed to satisfy market demand for ‘sample to answer’ IVD tools and enables sample extraction through to analysis with a single cartridge.

Trustonic’s hardware-backed security platform, TSP, allows secure and private data extraction, processing, storage and transmission. The technology provides a secure image processing channel from the sensor to the application processor, as well as cryptographic tools to protect sensitive medical data, ensures data integrity, creates a secure environment to run algorithms analyzing raw data from the sensor and encrypts sensitive data when being shared with the cloud.

More information

Related news

Security platform provides performance and flexibility

Infineon launches first certified NFC Type 4B Tag

Open source TPM 2.0 software stack eases security adoption

UK government funds ARM to develop security IP


If you enjoyed this article, you will like the following ones: don't miss them by subscribing to :    eeNews on Google News